Ticker Details
Edwards Lifesciences Corp Edwards Lifesciences Corp is a part of the healthcare sector. The company specializes in the treatment of structural heart disease. It manufactures heart valves and repair products used to replace or repair a patient's diseased or defective heart valve.
IPO Date:	April 3, 2000
Sector:	Healthcare
Industry:	Health Care Equipment and Supplies
Market Cap:	$44.9B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.97 | 1.07%
Avg Daily Range (30 D):	$0.92 | 1.11%
Avg Daily Range (90 D):	$0.89 | 1.08%

Institutional Daily Volume
Avg Daily Volume:	1.7M
Avg Daily Volume (30 D):	3.63M
Avg Daily Volume (90 D):	3.25M

Trade Size
Avg Trade Size (Sh.):	105
Avg Trade Size (Sh.) (30 D):	65
Avg Trade Size (Sh.) (90 D):	63

Institutional Trades
Total Institutional Trades:	28,776
Avg Institutional Trade:	$6.16M
Avg Institutional Trade (30 D):	$8.15M
Avg Institutional Trade (90 D):	$7.81M
Avg Institutional Trade Volume:	.15M
Avg Institutional Trades (Per Day):	5

Market Closing Trades
Avg Closing Trade:	$22.28M
Avg Closing Trade (30 D):	$67.41M
Avg Closing Trade (90 D):	$58.56M
Avg Closing Volume:	407.69K

News

Feb 20, 2026 @ 5:02 AM ORBIMED Advisors Trims $125 Million Terns Stake Af... Source: Eric Trie

Feb 17, 2026 @ 9:00 AM Pulmonary Artery Catheter Market Size to Reach USD... Source: Sns Insider

Jan 15, 2026 @ 1:42 PM Boston Scientific Acquires Penumbra In $14.5 Billi... Source: Akanksha Bakshi

Jan 12, 2026 @ 2:31 PM Court Ruling Ends Edwards Lifesciences $1.2 Billio... Source: Vandana Singh

Jan 12, 2026 @ 12:52 PM Global Catheters Market Size to Hit USD 55.58 Bill... Source: Sns Insider

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$1.84	$.16	$1.84
Diluted EPS	$1.83	$.16	$1.83
Revenue	$6.07B	$1.57B	$6.07B
Gross Profit	$4.73B	$1.23B	$4.73B
Net Income / Loss	$1.07B	$91.2M	$1.07B
Operating Income / Loss	$1.26B	$151.1M	$1.26B
Cost of Revenue	$1.33B	$343M	$1.33B
Net Cash Flow	$-119.3M	$244.7M	$-119.3M
PE Ratio	42.69

Splits
Jun 01, 2020	3:1
Dec 14, 2015	2:1
May 28, 2010	2:1